Expression of c-Kit and its ligand SCF in primary uveal melanoma

European Journal of Ophthalmology

Volumn 21, Issue 5, 2011, Pages 615-624

  Lüke, Julia ^a   Wegner, Jürgen ^b   Wegner, Rayime ^b   Nassar, Khaled ^a   Tatar, Olcay ^b   Rohrbach, Jens M ^b   Hilgers, Ralf Dieter ^c   Lüke, Matthias ^a   Grisanti, Salvatore ^a  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^b UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^c RWTH AACHEN UNIVERSITY   (Germany)

Author keywords

c Kit; Metastasis; Prognostic factors; Stem cell factor; Therapy; Uveal melanoma

Indexed keywords

PARAFFIN; STEM CELL FACTOR; STEM CELL FACTOR RECEPTOR;

ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; METASTASIS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; UVEA MELANOMA;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; LIVER NEOPLASMS; MALE; MELANOMA; MIDDLE AGED; NEOPLASM STAGING; PROTO-ONCOGENE PROTEINS C-KIT; STEM CELL FACTOR; TUMOR MARKERS, BIOLOGICAL; UVEAL NEOPLASMS;

EID: 79960825680     PISSN: 11206721     EISSN: None     Source Type: Journal    
DOI: 10.5301/EJO.2011.6292     Document Type: Article

References (25)

1. Singh AD, Borden EC. Metastatic uveal melanoma. Ophthalmol Clin North Am 2005; 18: 143-50
2. Kivela T, Eskelin S, Kujala E. Metastatic uveal melanoma. Int Ophthalmol Clin 2006; 46: 133-49
3. Lefèvre G, Babchia N, Calipel A, Activation of the FGF2/FGFR1 autocrine loop for cell proliferation and survival in uveal melanoma cells. Invest Ophthalmol Vis Sci 2009; 50: 1047-57
4. Zwick E, Bange J, Ullrich A. Receptor tyrosine kinase signalling as a target for cancer intervention strategies. Endocr Relat Cancer 2001; 8: 161-73
5. Fabbro D, Garcia-Echeverria C. Targeting protein kinases in cancer therapy. Curr Opin Drug Discov Dev 2002; 5: 701-12.
6. Ashman LK. The biology of stem cell factor and its receptor C-kit. Int J Biochem Cell Biol 1999; 31: 1037-51.
7. Huang S, Luca M, Gutman M, Enforced c-KIT expression renders highly metastatic human melanoma cells susceptible to stem cell factor-induced apoptosis and inhibits their tumorigenic and metastatic potential. Oncogene 1996; 13: 2339-47.
8. Ericsson C, Girnita L, Muller-Brunotte A, c-Kitdependent growth of uveal melanoma cells: a potential therapeutic target? Invest Ophthalmol Vis Sci 2004; 45: 2075-82.
9. Ronnstrand L. Signal transduction via the stem cell factor receptor/c-Kit. Cell Mol Life Sci 2004; 61: 2535-48.
10. Malignant melanoma of the uvea. In: Edge SD, Byrd DR, Carducci MA, Compton CC, eds. AJCC Cancer Staging Manual, 7th ed. New York, NY: Springer, 2009; 7-8.
11. Lin LI. A concordance correlation coefficient to evaluate reproducibility. Biometrics 1989; 45: 255-68.
12. Hofmann UB, Kauczok-Vetter CS, Houben R, Becker JC. Overexpression of the KIT/SCF in uveal melanoma does not translate into clinical efficacy of imatinib mesylate. Clin Cancer Res 2009; 15: 324-9.
13. Pereira PR, Odashiro AN, Marshall JC, Correa ZM, Belfort R Jr, Burnier MN Jr. The role of c-kit and imatinib mesylate in uveal melanoma. J Carcinog 2005; 4: 19.
14. Mouriaux F, Kherrouche Z, Maurage CA, Demailly FX, Labalette P, Saule S. Expression of the c-kit receptor in choroidal melanomas. Melanoma Res 2003; 13: 161-6.
15. Stefanou D, Batistatou A, Zioga A, Arkoumani E, Papachristou DJ, Agnantis NJ. Immunohistochemical expression of vascular endothelial growth factor (VEGF) and C-KIT in cutaneous melanocytic lesions. Int J Surg Pathol 2004; 12: 133-8.
16. Natali PG, Nicotra MR, Winkler AB, Cavaliere R, Bigotti A, Ullrich A. Progression of human cutaneous melanoma is associated with loss of expression of c-kit proto-oncogene receptor. Int J Cancer 1992; 52: 197-201.
17. Zakut R, Perlis R, Eliyahu S, KIT ligand (mast cell growth factor) inhibits the growth of KIT-expressing melanoma cells. Oncogene 1993; 8: 2221-9.
18. Lassam N, Bickford S. Loss of c-kit expression in cultured melanoma cells. Oncogene 1992; 7: 51-6.
19. Welker P, Schadendorf D, Artuc M, Grabbe J, Henz BM. Expression of SCF splice variants in human melanocytes and melanoma cell lines: potential prognostic implications. Br J Cancer 2000; 82: 1453-8.
20. Yue FY, Dummer R, Geertsen R, Interleukin-10 is agrowth factor for human melanoma cells and down-regulates HLA class-I, HLA class-II and ICAM-1 molecules. Int J Cancer 1997; 71: 630-7.
21. Mattei S, Colombo MP, Melani C, Silvani A, Parmiani G, Herlyn M. Expression of cytokine/growth factors and their receptors in human melanoma and melanocytes. Int J Cancer 1994; 56: 853-7.
22. Moretti S, Pinzi C, Spallanzani A, Immunohistochemical evidence of cytokine networks during progression of human melanocytic lesions. Int J Cancer 1999; 84: 160-8
23. Worley LA, Long MD, Onken MD, Harbour JW. Micro- RNAs associated with metastasis in uveal melanoma identified by multiplexed microarray profiling. Melanoma Res 2008; 18: 184-90.
24. Longley BJ, Carter EL. SCF-KIT pathway in human epidermal melanocyte homeostasis. J Invest Dermatol 1999; 113: 139-40.
25. Buchdunger E, Cioffi CL, Law N, Abl protein-tyrosine kinase inhibitor STI571 inhibits in vitro signal transduction mediated by c-kit and platelet-derived growth factor receptors. J Pharmacol Exp Ther 2000; 295: 139-45